Abstract

Background Patients with cancer pursue all possible opportunities of effective remedies. In Saudi Arabia, most patients have tried complementary medicine during their cancer treatment plan; however, some complementary medicines might pose a danger to health. In Arab countries, studies regarding the use of complementary medicines and the intentions behind using complementary medicines among cancer patients are inadequate and all but nonexistent. The aim of this review was to focus on demographic, prevalence, and reasons for complementary and alternative medicine use among patients with cancer. Methods A rigorous literature search was conducted for articles published in the English language, using the search terms “complementary and alternative medicine,” “oncology,” “malignancy” AND “cancer patients” in five scientific databases, namely, Medical Literature On-Line (MEDLINE), PubMed, Web of Science, Psychology Information (PsycINFO), and Google Scholar, from 2010 to 2020. Results Of the 13,160 studies returned from the search, only 12 were eligible and included in this review. The combined prevalence for using complementary and alternative medicines across all studies totaled 25%–80% of cancer patients for the treatment of their cancers. Natural products, including vitamins and minerals, herbal products, and relaxation, were the most common type of complementary and alternative medicines used. The reason for using complementary and alternative medicines was reported to be their helpfulness in recovering, healing, and improving health. Most of the studies mentioned that participants obtained their complementary and alternative medicines from multiple sources, including the media, family and friends, and physicians. Conclusion The use of complementary and alternative medicines in cancer patients can be inferred as an attempt to investigate all possibilities, a manifestation of a coping style, or an illustration of unmet desires in the cancer management continuum. Anyhow, there should be adequate communication between healthcare providers and patients, which is crucial for establishing a trusting healthcare provider-patient relationship. Relevance to clinical practice. It is crucial that healthcare providers explore the use of complementary and alternative medicines with their cancer patients, as well as educating them about the possible usefulness of therapies based on the available evidence.

Highlights

  • Cancer is deliberated as a common health problem, associated with significant disabilities, and is one of the three leading causes of death worldwide [1]

  • According to the World Health Organization (WHO), it is estimated that cancer rates will be increased by 50% to 15 million by 2030. us, most cancer patients and their families seek all possible options related to effective treatment to manage the trauma of distress, worries, and immense fear associated with their condition [2, 3]

  • Some patients explore complementary and alternative medicine (CAM) choices, which constitute a type of medicine independent of conventional medicine. is practice is widely used across the world and can be explained as any usage that is not part of conventional medicine [4]

Read more

Summary

Introduction

Cancer is deliberated as a common health problem, associated with significant disabilities, and is one of the three leading causes of death worldwide [1]. Numerous patients that feel worried decide to leave their course of conventional medicine and instead seek help via complementary and alternative medicines, which are gaining increasing interest, especially in the field of oncology [5]. Due to this trend, patients’ interests should be given due deliberation in current oncology practices and Evidence-Based Complementary and Alternative Medicine should be addressed in such a way as to provide recommendations regarding acceptable and individualized therapy merged with supportive care, including CAMs, under standardized oncology protocols [6]. It is crucial that healthcare providers explore the use of complementary and alternative medicines with their cancer patients, as well as educating them about the possible usefulness of therapies based on the available evidence

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call